IndieBio
World's leading biotech accelerator and SOSV program, accelerating early-stage biotech startups with up to $525K in funding across locations in San Francisco and New York.
San Francisco, United States · 106+ investments · 115 portfolio companies
- Headquarters
- San Francisco, United States
- Founded
- 2015
- Website
- indiebio.co
- AUM
- $1.5B
- Portfolio Companies
- 115
- Total Investments
- 106
- Last Investment
- Jan 2026
- Geographic Focus
- United States
Indexed holds 115 portfolio companies and 106 funding rounds for this investor. The full record is or through the API.
Investment Thesis
IndieBio is an Accelerator based in San Francisco, United States. It has made 106 investments, including GOZEN, Ivy Natal and Dandelion Health. Focus areas include Biotech and Climate Tech.
Portfolio115
Showing 48 of 115 recorded portfolio companies.
Co-investors24
Sign up to view co-investors
24 co-investors across 158 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×16 · Accelerator ×5 · Hedge Fund ×1 · 103 shared rounds
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/indiebio"><img src="https://indexed.vc/api/badge/investor/indiebio" alt="IndieBio on Indexed.vc" width="260" height="76" /></a>